Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 31.6% in First Quarter of 2023
Listen to the full version

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 718.3 million yuan in the first quarter of 2023, up 31.6% year-on-year.
Meanwhile, the company posted 2.1 billion yuan in revenue, up 22.4% year-on-year.
At the end of the reporting period, it had 31 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 5.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR